GSK Says It Will Spend $30B on U.S. Manufacturing and R&D
1. GSK plans a $30 billion investment in U.S. over the next five years. 2. This investment includes a $1.2 billion manufacturing factory in Pennsylvania. 3. GSK's U.S. sales account for over 50% of its revenue. 4. GSK aims to mitigate tariff risks through this infrastructure investment. 5. The company is enhancing its R&D and supply chain capabilities in the U.S.